EXPERIMENTAL INSIGHTS INTO NEUROPROTECTIVE AND CARDIOPROTECTIVE MECHANISMS OF HERBAL BIOACTIVE COMPOUNDS

INTRODUCTION

The worldwide epidemiological pattern now shows non-communicable diseases as the main health threat which includes neurodegenerative disorders and cardiovascular diseases as the top causes of disease and death throughout the globe. The global population now experiences a rapid increase in chronic diseases because older people live longer and urban development leads to restricted physical activity. Medical professionals have approached NDDs and CVDs as two separate medical conditions which require different medical treatments. The existing preclinical and clinical studies provide strong evidence for the existence of a "heart-brain axis" which demonstrates complete interconnectedness between both systems. The two conditions display distinct clinical signs which manifest as cognitive decline and motor dysfunction in NDDs and ischemic events and heart failure in CVDs yet they exhibit identical pathophysiological patterns. The brain and heart tissues in this process lose their ability to create new cells because they already reach a state of completed development while they maintain high levels of energy usage and need constant supplies of oxygen and glucose. The three main pathological forces which operate on them create a double-edged sword of danger because they all result in oxidative damage and lead to chronic low-grade inflammation and destroy mitochondrial function.

The excessive production of reactive oxygen species (ROS) in both disease states causes the body's natural antioxidant systems to fail, which results in lipid peroxidation and protein misfolding and DNA damage. The brain microglia and vascular macrophages active their immune functions to create a toxic environment through their ongoing production of pro-inflammatory cytokines which includes TNF-α and IL-1β and IL-6. The stress factors lead to mitochondrial permeability changes which result in ATP depletion followed by the start of apoptotic pathways that result in permanent loss of neuronal and myocardial cells.

The standard approach to pharmacological treatment involves using medications that target a single disease aspect. Single-target therapies provide temporary relief for acute symptoms, but they do not stop or reverse the complex disease progression that results from multiple factors, & they cause both dose-limiting side effects and the development of drug resistance.

There is now an accepted scientific movement that investigates the medicinal properties of herbal bioactive compounds as effective treatment options. The phytochemicals in medicinal plants which include polyphenols and flavonoids and alkaloids function as secondary metabolites that create a diverse range of biological effects. The bioactive compounds from natural sources possess the ability to simultaneously control multiple cellular signaling mechanisms, which differentiates them from synthetic drugs that target specific pathways. The multi-target-directed ligands serve as agents that both eliminate free radicals and prevent inflammatory transcription factors from functioning while enhancing the body's natural cellular protection systems.

The review combines all current experimental data which scientists have obtained through both laboratory and live organism testing to show how herbal compounds protect the central nervous system and cardiovascular system through their exact molecular pathways. The article establishes a connection between traditional ethnomedicine and modern molecular pharmacology by mapping how specific bioactive compounds control essential signaling networks that include the Nrf2/HO-1 antioxidant pathway and the NF-κB inflammatory axis and the PI3K/Akt survival cascade. The study shows how phytochemicals can operate as two protective agents which safeguard human health.

Key Herbal Bioactive Compounds

Plants developed their secondary metabolites as advanced protective systems which defend against environmental stressors and ultraviolet radiation and biological threats. The diverse structural composition of these compounds enables them to bind with different human cell receptors and human enzymes and human transcription factors. The ability of this system to target multiple sites leads to its substantial effectiveness in protecting two different body tissues. The most extensively researched classes include:

· Polyphenols: The entire category which contains multiple phenol structural units displays strong free-radical scavenging capabilities as its most important feature. The main active compounds of this group are Resveratrol which exists naturally as a stilbene found in grapes and Curcumin which comes from the rhizomes of Curcuma longa and Epigallocatechin gallate which serves as the main active catechin in green tea. The chemical structure of these compounds includes highly conjugated double bonds together with phenolic hydroxyl groups which enable their function as powerful electron donors that combat reactive oxygen species (ROS).

· Flavonoids: Flavonoids serve as a common subclass of polyphenols which all display a distinctive 15-carbon skeletal structure. Quercetin which exists in high quantities within apples and onions together with its glycoside Rutin demonstrate strong metal-chelating abilities. The material stops Fenton reactions from driving iron and copper reactions which lead to lipid peroxidation in cardiac and neural cellular membranes.

· Alkaloids and Terpenoids: Alkaloids function as nitrogenous organic compounds which create specific physiological effects while polyphenols do not. Berberine functions as an isoquinoline alkaloid which scientists consider to be the only compound that controls metabolic processes and reduces body fat. The terpenoid Ginkgolides derived from Ginkgo biloba functions as a PAF receptor antagonist which completely stops microthrombus formation while maintaining blood flow in both the heart and brain.

Mechanisms of Neuroprotection

Researchers developed experimental models to study neurodegeneration and cerebral ischemia which revealed essential pathways that bioactive compounds use to safeguard neurons. The central nervous system (CNS) protection exists because the blood-brain barrier (BBB) maintains its strict boundary which enables phytochemicals with moderate lipophilicity, including resveratrol and curcumin, to pass through this protective barrier. The compounds enter brain tissue to produce direct neuroprotective effects through multiple molecular targets.

Attenuation of Oxidative Stress via the Nrf2/ARE Pathway

The brain has greater vulnerability to oxidative damage from reactive oxygen species because of its high oxygen consumption and its abundant myelin sheaths and its limited capacity to produce internal antioxidant protection. The compounds curcumin and resveratrol function as strong electrophiles that interact with the highly reactive cysteine sites of the Keap1 homodimer. The structural change enables the nuclear factor erythroid 2-related factor 2 (Nrf2) to separate from its bound repressor protein. After Nrf2 achieves freedom, it moves to the nucleus where it forms a complex with small Maf proteins to target antioxidant response elements (ARE). The binding causes strong gene expression of multiple protective enzymes and phase II detoxification enzymes which include Heme Oxygenase-1 (HO-1) Superoxide Dismutase (SOD) and NAD(P)H quinone oxidoreductase 1 (NQO1) and the enzymes that control glutathione (GSH) production.

Nrf2 Keap1 ARE pathway oxidative stress diagram, AI generated

Modulation of Neuroinflammation

The persistent neuroinflammation of chronic neuroinflammation occurs because resident microglia and astrocytes continue to function in their activated state. The activated glial cells start to produce a wide range of neurotoxic pro-inflammatory cytokines which include TNF-α and IL-1β and IL-6. The IκB kinase (IKK) complex functions as a target for herbal bioactives which produce strong anti-inflammatory effects through their direct action. The process blocks IκB from being degraded through phosphorylation because it prevents the NF-κB dimer from entering the nucleus by keeping it in the cytoplasm. Phytochemicals stop NF-κB from entering the nucleus which leads to two effects: they block primary inflammatory cytokine transcription and they decrease secondary tissue-damaging mediators which include inducible nitric oxide synthase and cyclooxygenase-2. The process successfully transforms microglial cells from a toxic M1 state into a M2 state which supports tissue repair.

Anti-apoptotic Signaling and Mitochondrial Preservation

Mitochondrial dysfunction acts as a critical executioner in neuronal death because it brings about mitochondrial membrane potential collapse which triggers cytosolic cytochrome c release that leads to apoptosome creation. Phytochemicals demonstrate essential neuroprotective effects through their ability to affect the natural process that leads to cell death. They cause Bcl-2 family regulatory proteins to lose their normal balance between Bcl-2 which functions as an anti-apoptotic guardian protein and Bax which acts as a pro-apoptotic pore-forming protein. This process stabilizes the system which results in the prevention of caspase-9 and executioner caspase-3 activation. Compounds such as EGCG and curcumin do not stop cell death but instead help neurons recover by increasing Brain-Derived Neurotrophic Factor BDNF levels. The bioactives activate the BDNF/TrkB signaling axis which activates survival cascades to support neurogenesis and dendritic arborization and long-term synaptic plasticity.

Mechanisms of Cardioprotection

Cardioprotective strategies protect heart muscle tissue through their ability to safeguard tissue during acute ischemic episodes and their capacity to stop post-heart-attack dangerous body changes and their function to protect blood vessel function over time. The adult heart has extremely restricted ability to regenerate which makes it essential to safeguard existing heart muscle cells from dying through necrosis and apoptosis. Herbal bioactives provide strong defense through their ability to attack both blood vessel structure and heart muscle tissue.

Endothelial Function and Vasodilation

The primary initiating precursor to atherosclerosis and hypertensive heart disease develops through endothelial dysfunction, which produces a dual effect of reduced nitric oxide (NO) bioavailability and conversion to a pro-inflammatory condition. Flavonoids such as quercetin, alongside polyphenols like resveratrol, potently counter this by enhancing endothelial nitric oxide synthase (eNOS) expression and enzymatic activity. The cardioprotective effect operates through phosphoinositide 3-kinase (PI3K)/Akt survival signaling pathway activation, which results in eNOS phosphorylation at the essential Ser1177 site. The increased production of NO spreads through nearby vascular smooth muscle cells, which leads to cGMP synthesis and continuous strong vasodilation. The body uses restored NO levels to stop harmful platelet aggregation, while it also prevents the production of cellular adhesion molecules, including VCAM-1 and ICAM-1, which would lead to leukocyte attachment and movement into the vascular intima.

Mitigation of Ischemia-Reperfusion (I/R) Injury

The medical process needs to restore blood circulation through reperfusion treatment during an acute myocardial infarction because this procedure serves as the fundamental requirement for patient survival. The process of blood restoration through rapid medical treatment creates a paradoxical outcome because it leads to severe tissue destruction through a substantial release of reactive oxygen species and excessive build-up of intracellular calcium. The phytochemicals resveratrol and Ginkgo biloba extracts provide strong protection against ischemia-reperfusion I/R injury according to scientific research. The chemical compounds directly affect cardiac mitochondrial processes by enabling the opening of mitochondrial ATP-sensitive potassium channels mKATP which results in reduced inner membrane potential and oxidative burst. The bioactive compounds effectively block the severe mitochondrial permeability transition pore mPTP which typically occurs during calcium overload. The compounds maintain mPTP closure which protects mitochondria from swelling and membrane rupture and prevents the start of apoptotic processes which helps to maintain heart tissue health while decreasing the total infarct area.

Regulation of Lipid Metabolism

The body needs to control blood fat levels because it helps maintain heart health for an extended period. Berberine and other alkaloids deliver strong heart protection because they control how the liver processes fats. Berberine functions differently from traditional statins because it leads to increased production of low-density lipoprotein receptors through its special mechanism which operates after transcription. The process maintains LDLR mRNA stability through particular extracellular kinase pathways while it decreases PCSK9 protein levels which usually breaks down LDL receptors. This dual action maintains LDL receptors on hepatocyte surfaces for extended periods which results in rapid LDL cholesterol removal from blood and prevents atherosclerotic plaque growth.

Heart-Brain Cross-Talk: Dual Protective Agents

The new scientific model known as the "heart-brain axis" demonstrates that human physiology depends on heart health to maintain brain function. Heart failure and microvascular dysfunction both create chronic cerebral hypoperfusion which leads to faster neurodegenerative development. Small vessel disease has become recognized as the main pathological cause of vascular dementia while also worsening Alzheimer’s disease progression. The two bioactive compounds resveratrol and curcumin show multiple protective effects which make them essential for safeguarding against danger. These phytochemicals protect heart muscles and brain systems because they reduce cytokine levels and control oxidative stress in the body. The body uses these substances to boost endothelial cells which produce nitric oxide to prevent atherosclerotic plaque rupture that leads to myocardial infarction. Systemic anti-inflammatory processes protect blood-brain barrier (BBB) structural integrity in the cerebrovascular network. The compounds prevent peripheral neurotoxic immune cells from entering the brain parenchyma by blocking matrix metalloproteinase (MMP) activities which destroy endothelial tight junction proteins claudins and occludins.

Challenges and Future Perspectives

The successful clinical application of herbal bioactives faces major obstacles because of their serious pharmacokinetic constraints despite exceptional experimental evidence which supports their effectiveness. The main issues which affect these systems arise from three specific factors which include their limited ability to dissolve in water and their fast metabolic breakdown through hepatic first-pass processing and their complete inability to cross the blood-brain barrier. Many polyphenols undergo extensive Phase II conjugation (glucuronidation and sulfation) in the gastrointestinal tract and liver, resulting in their rapid elimination from the body and their inability to achieve effective therapeutic plasma levels. The body prevents central nervous system access through the active function of efflux transporters which include P-glycoprotein that operate on brain capillary endothelial cells.To overcome these formidable translational barriers, future research must urgently prioritize:

· Nanotechnology: Research requires the creation of new nanocarrier systems which include solid lipid nanoparticles and liposomes and polymeric dendrimers. The process of encapsulation protects bioactive substances from early enzymatic breakdown while it enables their passage through the blood-brain barrier via receptor-mediated transcytosis and their specific gathering in damaged heart tissue.

· Synergistic Formulations: The research about how different phytochemicals interact with each other shows potential for developing new medical treatments. The combination of curcumin and piperine which is an alkaloid found in black pepper serves as an effective method to block hepatic and intestinal UDP-glucuronosyltransferases and CYP450 enzymes. The targeted inhibition mechanism blocks the quick glucuronidation process which results in curcumin achieving 2000 times higher systemic bioavailability.

· Rigorous Clinical Trials: The field must conduct its research through double-blind placebo-controlled human clinical trials which require precise study design to advance beyond current preclinical testing that uses in vitro and mouse models. The process of establishing standardized botanical extract compositions needs to start with researchers determining specific pharmacokinetic details while using biomarker endpoints to prove safe and effective dosing methods.

Conclusion

The increasing worldwide occurrence of combined cardiovascular and neurodegenerative diseases demands that we change our current treatment methods. The neuroprotective and cardioprotective abilities of herbal bioactive compounds have been established through extensive research which makes these compounds excellent choices for treating these linked diseases. Phytochemicals including polyphenols and flavonoids and alkaloids function as advanced network pharmacodynamic agents which differ from traditional synthetic drugs that target only one specific area of the body. The compounds found in nature provide a complete solution to complex chronic disease treatment through their ability to enhance vital body defenses against oxidative damage and their capability to stop ongoing brain and body inflammation through their exact NF-κB suppression and their ability to control mitochondrial cell death processes through their PI3K/Akt and Bcl-2/Bax signaling pathways. The body needs to treat the "heart-brain axis" as a single interconnected system because their particular ability to maintain complete endothelial function throughout the body and maintain the blood-brain barrier demonstrates their value.

The scientific field continues to struggle with the basic challenge of bringing successful preclinical research from mouse and laboratory studies into standard medical practice. The process of transforming experimental findings into useful medical treatments needs dedicated work from multiple scientific disciplines. The field of phytomedicine will advance to its next essential development through the combination of cutting-edge nanotechnology delivery systems which solve existing bioavailability problems together with newly developed botanical formulations which have been strategically created for combination effects. The complete medical value of these bioactive substances can only be achieved through extensive human clinical studies which need strict experimental controls and specific biomarker measurements. Herbal bioactives become valuable as primary prevention and treatment solutions against age-related neurological and cardiovascular diseases if researchers can resolve the existing pharmacokinetic challenges.

ACKNOWLEDGMENTS

None.

REFERENCES

Aggarwal, B. B., and Harikumar, K. B. (2009). Potential Therapeutic Effects of Curcumin, the Anti-Inflammatory Agent, against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases. The International Journal of Biochemistry and Cell Biology, 41(1), 40–59. https://doi.org/10.1016/j.biocel.2008.06.010

Balaraju, P., and Kumar, S. (2022). Phytochemical Modulation of the Nrf2/ARE Axis: Implications for Neurodegenerative Diseases. Journal of Ethnopharmacology, 285, 114867. https://doi.org/10.1016/j.jep.2021.114867

Bhat, K. P. L., Kosmeder, J. W., and Pezzuto, J. M. (2001). Biological Effects of Resveratrol. Antioxidants and Redox Signaling, 3(6), 1041–1064. https://doi.org/10.1089/152308601317203567

Bøgelund, N., and Pedersen, L. (2019). The Heart-Brain Axis: Vascular Health and Its Impact on Cognitive Decline. Neurobiology of Aging, 76, 12–21. https://doi.org/10.1016/j.neurobiolaging.2018.12.005

Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Iavicoli, I., Di Pietro, V., Koverech, A., ... and Calabrese, E. J. (2012). Cellular Stress Responses, Hormetic Phytochemicals and Vitagenes in Aging and Longevity. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1822(5), 753–783. https://doi.org/10.1016/j.bbadis.2011.11.002

D'Andrea, G. (2015). Quercetin: A Flavonol with Multifaceted Therapeutic Applications? Fitoterapia, 106, 256–271. https://doi.org/10.1016/j.fitote.2015.09.018

Ghosh, D., and Scheepens, A. (2009). Vascular Action of Polyphenols. Molecular Nutrition and Food Research, 53(3), 322–331. https://doi.org/10.1002/mnfr.200800182

Habtemariam, S. (2019). The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol. Oxidative Medicine and Cellular Longevity, 2019, 4724920. https://doi.org/10.1155/2019/4724920

Kizhakekuttu, T. J., and Widlansky, M. E. (2010). Natural Antioxidants and Hypertension: Promise and Challenges. Cardiovascular Therapeutics, 28*(4), e20–e32. https://doi.org/10.1111/j.1755-5922.2010.00137.x